Skip to main content
Panda Surgical logo

Panda Surgical

London, EnglandFounded 2022

  • Seed

Panda Surgical is a UCL spinout developing Victor, a handheld surgical robotic system that combines AI and robotics to support minimally invasive procedures. Born in neurosurgery at Queen Square, the company aims to make surgery safer and more effective through smaller openings.

Raised
$2.7M
Oct 2025
Seed
Investors
4
Founded
2022
Employees
1–10

reccy insights

Recent highlights

Panda Surgical’s clearest recent financing milestone was non-equity assistance from MedTech Innovator, dated May 27, 2026; no amount is specified. The company’s £1 million seed round is dated Oct 5, 2025 and lists OTIF Ventures, New Wave Ventures, and UCLB among its investors. A separate financial signal gives a Sep 26, 2025 date for a £1 million strategic investment involving Oxford Investment Consultants and New Wave Ventures, suggesting a date or round-label discrepancy around the seed financing. Earlier support includes an NIHR i4i PDA grant of over £1 million, dated Dec 11, 2024, and a £45,211 NIHR i4i FAST award, dated May 3, 2023. On the team side, hiring signals note an added senior mechanical engineer in January 2026, following an embedded software engineer in August 2024 and a quality engineer in June 2024.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Panda Surgical distinct

  1. 01Combines AI and robotics in a handheld system designed for minimally invasive surgery.
  2. 02Focuses on neurosurgery, with the stated aim of bringing surgical robotics into more routine practice.
  3. 03Develops technology for procedures in confined brain and spine spaces, where dexterity and visualization are important.
  4. 04The team spans surgery, engineering, science, design, regulation, and commercial leadership.

Technology & products

  • Victor

    A handheld surgical robotic system for minimally invasive procedures, combining robotic instruments with AI-assisted software.

  • Victor, a handheld robotic system for minimally invasive surgery.
  • AI-assisted real-time anatomy segmentation.
  • AI-assisted surgery phase recognition.
  • A platform combining wristed surgical instruments, robotic control, and software.

Recent updates6

  • Sep 10, 2026Award

    Panda Surgical awarded Innovate UK funding to develop an AI co-pilot for robotic neurosurgery

    panda-surgical.com
  • Aug 12, 2026Team change

    Panda Surgical appoints Craig Marshall as Chairman of the Board

    panda-surgical.com
  • May 27, 2026Award

    Panda Surgical selected for prestigious MedTech Innovator 2026 Accelerator cohort

    panda-surgical.com

Funding

$2.7M disclosed
  • Non-Equity AssistanceMay 2026
  • SeedOct 2025
    $1.3MLed by OTIF Ventures, New Wave Ventures, UCLB, Oxford Investment Consultants
  • NIHR i4i PDA GrantDec 2024
    $1.3MLed by NIHR Invention for Innovation (i4i) PDA grant
4 investors

About Panda Surgical

Products
Victor
Leadership
Dan Stoyanov, Co-Founder and Scientific AdvisorManios Dimitrakakis, Co-Founder and CEOHani Marcus, Co-Founder and Chief Medical Officer
Focus areas
Surgical robotics, minimally invasive surgery, neurosurgery, AI, medical devices, healthcare technology, robotics, UCL spinout
Headquarters
London, England
Founded
2022
Employees
1–10
Patents granted
5
Trademarks
4